Mars CEO gets board role at GLP-1 supplier Novo Nordisk

Leave a Comment / Procesos Alimentarios / By
Bookmark (0)
Please login to bookmark Close

Novo Nordisk, one of the principal suppliers of GLP-1 weight-loss medication, has handed a board role to the chief executive of Mars.Novo Nordisk, one of the principal suppliers of GLP-1 weight-loss medication, has handed a board role to the chief executive of Mars. Read More

Related posts:

Default ThumbnailMars CEO gets board role at GLP-1 supplier Novo Nordisk Default ThumbnailPepsiCo CEO sees “big opportunities” from GLP-1 drugs Default ThumbnailConagra 1st to Add ‘GLP-1 Friendly’ Label to Food Packaging Default ThumbnailKroger Health’s The Little Clinic Taps Into Weight Loss Craze Default ThumbnailPepsiCo CEO sees “big opportunities” from GLP-1 drugs Default ThumbnailLamb Weston announces appointment of Michael J Smith as president and chief executive officer